1-3 of 3
S Bregante
Close
Sort by
Journal Articles

Leukemia Relapse after Allogeneic Transplants in AML: Predictive Role of WT1 Expression and Protective Effect of DLI.

Andrea Bacigalupo, MD, A. Dominietto, C. Di Grazia, S. Pozzi, F. Bertolotti, M. Podesta’, T. Lamparelli, F. Gualandi, I. Ibatici, S. Bregante, V. Pinto, F. Frassoni
Journal: Blood
Blood (2008) 112 (11): 3263.
https://doi.org/10.1182/blood.V112.11.3263.3263
Published: 2008
Journal Articles

Low Transplant Mortality in Allogeneic Bone Marrow Transplantation for Acute Myeloid Leukemia: A Randomized Study of Low-Dose Cyclosporin Versus Low-Dose Cyclosporin and Low-Dose Methotrexate

P. Zikos, M.T. Van Lint, F. Frassoni, T. Lamparelli, F. Gualandi, D. Occhini, N. Mordini, G. Berisso, S. Bregante, F. De Stefano, M. Soracco, V. Vitale, A. Bacigalupo
Journal: Blood
Blood (1998) 91 (9): 3503–3508.
https://doi.org/10.1182/blood.V91.9.3503
Published: 1998
Journal Articles

Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia

A Bacigalupo, MT Van Lint, M Valbonesi, G Lercari, P Carlier, T Lamparelli, F Gualandi, D Occhini, S Bregante, A Valeriani, G Piaggio, A Pitto, F Benvenuto, O Figari, G De Stefano, A Caimo, M Sessarego
Journal: Blood
Blood (1996) 88 (1): 353–357.
https://doi.org/10.1182/blood.V88.1.353.353
Published: 1996